Physician

Jayanthi R Ramadurai, MD

According to 2025 Medicare claims, Jayanthi Ramadurai, MD (NPI: 1639196330) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is AFFILIATED ONCOLOGISTS, LLC (NPI: 1225314362; TIN: 274182621) and primary practice location at 60415-2717. Ramadurai is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and AMITA Health Accountable Care Organization, LLC (ACO ID: A1501), participating under the MSSP model.

Ramadurai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 909 traditional Medicare patients, billed 212,867 HCPCS/CPT codes, and received $4,019,510 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,629 prescription claims across 381 beneficiaries totaling $3,326,153 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 49 claims. Open Payments data shows 169 records totaling $3,713. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,193,105 to $4,019,510. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,215,426 to $3,326,153. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,145 and ending at $3,602.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $1,193,105 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,349,183 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,894,636 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,537,476 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,261,583 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,828,618 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,642,508 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,568,546 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,008,423 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,019,510 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201551861,250$1,193,105
201650391,280$1,349,183
2017469118,634$1,894,636
2018806166,337$2,537,476
2019917227,295$3,261,583
2020932260,142$3,828,618
2021959326,158$4,642,508
2022913293,753$4,568,546
2023911238,935$4,008,423
2024909212,867$4,019,510

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.4M2015 Drug cost: $1,215,426 (USD; Tot_Drug_Cst)2016 Drug cost: $1,485,384 (USD; Tot_Drug_Cst)2017 Drug cost: $2,033,212 (USD; Tot_Drug_Cst)2018 Drug cost: $1,793,200 (USD; Tot_Drug_Cst)2019 Drug cost: $2,229,387 (USD; Tot_Drug_Cst)2020 Drug cost: $2,828,069 (USD; Tot_Drug_Cst)2021 Drug cost: $3,369,100 (USD; Tot_Drug_Cst)2022 Drug cost: $3,131,062 (USD; Tot_Drug_Cst)2023 Drug cost: $3,306,906 (USD; Tot_Drug_Cst)2024 Drug cost: $3,326,153 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151991,371$1,215,426
20162331,371$1,485,384
20172141,066$2,033,212
20182261,017$1,793,200
20192561,138$2,229,387
20202651,286$2,828,069
20213091,457$3,369,100
20223121,227$3,131,062
20233921,751$3,306,906
20243811,629$3,326,153

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$29K2015 Medicare payment: $29,492 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $16,320 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $17,367 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,363 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $7,830 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $10,146 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $7,370 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,213 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,969 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R79$29,492
2016N/R28$16,320
2017N/R80$17,367
2018N/R11$4,363
2019N/R50$7,830
202011103$10,146
20212988$7,370
2022N/R14$1,213
20231149$8,969
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less163496$104
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5491,780$99
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less110369$22
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's245554$13
96372Injection of drug or substance under skin or into muscle134421$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide33924$670,442
VerzenioAbemaciclib22616$338,754
PomalystPomalidomide14392$329,907
ImbruvicaIbrutinib19544$248,330
IbrancePalbociclib14392$221,400

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.169$3,713AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jayanthi R. Ramadurai, MD?

Tedicare shows public-source Medicare data for Jayanthi R. Ramadurai, MD (NPI 1639196330), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jayanthi R. Ramadurai, MD have ACO affiliation data?

Jayanthi R. Ramadurai, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and AMITA Health Accountable Care Organization, LLC (MSSP, ACO ID A1501).

What billing organization is linked to Jayanthi R. Ramadurai, MD?

Jayanthi R. Ramadurai, MD is linked to AFFILIATED ONCOLOGISTS, LLC (billing NPI 1225314362) in the available physician profile data.

Does Jayanthi R. Ramadurai, MD have Open Payments data?

Jayanthi R. Ramadurai, MD has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.